News Image

Tuesday's pre-market session: top gainers and losers

By Mill Chart

Last update: Apr 23, 2024

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Pre-market gainers

TickerChangeComment
CYN95.95%CYNGN INC (NASDAQ:CYN) recorded a 95.95% increase in share price during the pre-market session, reaching $0.24 on Tuesday. Also in the previous session NASDAQ:CYN had a very good day: shares closed with a 11.93% gain.
PEGY43.67%During Tuesday's pre-market session, PINEAPPLE ENERGY INC (NASDAQ:PEGY) exhibited strong growth, with the stock price climbing 43.67% to $0.07. NASDAQ:PEGY seems to be recovering from a -10.2% loss in the previous session.
SMFL42.99%SMART FOR LIFE INC's (NASDAQ:SMFL) shares surged 42.99% to reach $6.22 during the pre-market session on Tuesday. Yesterday's gain of 804.0% continues in today's pre-market with 42.99%.
HWH38.28%HWH INTERNATIONAL INC's (NASDAQ:HWH) shares surged 38.28% to reach $1.77 during the pre-market session on Tuesday. The stock is trading 20.75% higher than a month ago.
NKGN24.49%NKGEN BIOTECH INC (NASDAQ:NKGN) rose 24.49% to $1.83 during Tuesday's pre-market session. Today's pre-market session builds upon the previous day's success, as NASDAQ:NKGN continues its upward trajectory following a 32.91% gain.
ICUCW23.76%LMF ACQUISITION OPP -A -CW26's (NASDAQ:ICUCW) stock price is advancing with 23.76% to a price of $0.1. After yesterday's drop of -10.22%, it looks like it is bouncing back in today's pre-market session.
TLSA21.99%Pre-market trading on Tuesday showed positive momentum for TIZIANA LIFE SCIENCES LTD (NASDAQ:TLSA), as the stock price advanced 21.99% to reach $0.92. The positive momentum from yesterday's 13.15% gain carries forward into today's pre-market session, with an additional 21.99% increase. yesterday the company released their earnings. Earlier today the company had a press release: Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program.
CXAIW21.18%During Tuesday's pre-market session, KINS TECH GROUP CL A -CW25 (NASDAQ:CXAIW) experienced a 21.18% increase, with the stock price reaching $0.36. The stock is trading 48.5% higher than a month ago.
SAVAW20.93%CASSAVA SCIENCES INC-28's (NASDAQ:SAVAW) stock price increased by 20.93% to $0.52. Shareholders saw the stock price going 89.81% lower in the past month.
HIBB18.84%HIBBETT INC's (NASDAQ:HIBB) stock price increased by 18.84% to $86.15. A press release (Hibbett, Inc. Announces Definitive Agreement to be Acquired by JD Sports Fashion plc) was released earlier today.

For the full premarket gainers list go to our premarket gainers page.

Today's pre-market losers

TickerChangeComment
DCFC-62.91%TRITIUM DCFC LTD's (NASDAQ:DCFC) stock price decreased by 62.91% to $1.35. Shareholders saw the stock price going 73.62% lower in the past month.
ABEO-46.74%ABEONA THERAPEUTICS INC's (NASDAQ:ABEO) stock price recorded a 46.74% decrease, falling to $3.92. A press release (Abeona Therapeutics Provides Regulatory Update on Pz-cel) was released yesterday.
GWAV-44.42%Investors observed a 44.42% decline in GREENWAVE TECHNOLOGY SOLUTIO's (NASDAQ:GWAV) stock price, which now stands at $0.07 during Tuesday's pre-market session. Shareholders saw the stock price going 85.36% lower in the past 3 months.
CALX-15.76%The stock price of CALIX INC (NYSE:CALX) is experiencing a decline of 15.76%, reaching $24.9 in today's pre-market session on Tuesday. A press release (Calix Releases First Quarter 2024 Financial Results) was released yesterday.
PHIO-15.51%PHIO PHARMACEUTICALS CORP's (NASDAQ:PHIO) shares fell 15.51% to $0.7. After running up 29.69% in yesterday's session, NASDAQ:PHIO is pulling back pre-market.
TTOO-12.97%T2 BIOSYSTEMS INC's (NASDAQ:TTOO) shares fell 12.97% to $2.75 during Tuesday's pre-market session. In the last 3 months the share price dropped with 25.12%.
CSLR-12.62%COMPLETE SOLARIA INC's (NASDAQ:CSLR) stock price decreased by 12.62% to $0.34. Yesterday's drop of -13.53% continued in today's pre-market session with another decline of 12.62% A press release (Retail Stock Sector and Chairman T.J. Rodgers Invest in Complete Solaria) was released two days ago.
SSL-11.85%The stock price of SASOL LTD-SPONSORED ADR (NYSE:SSL) is experiencing a decline of 11.85%, reaching $6.99 in today's pre-market session on Tuesday. Shareholders saw the stock price going 39.51% lower is the past 6 months.
JAGX-11.4%Tuesday's pre-market session showed a 11.4% decrease in the stock price of JAGUAR HEALTH INC (NASDAQ:JAGX), reaching $0.16. After a strong performance yesterday with a 14.66% gain, NASDAQ:JAGX shows signs of retracement with a 11.4% decline in today's pre-market session.
SPCB-10.98%Investors observed a 10.98% decline in SUPERCOM LTD's (NASDAQ:SPCB) stock price, which now stands at $0.26 during Tuesday's pre-market session. Prices are quite volatile now: this is a reversal from yesterday's 31.68% gain.

For the full premarket loser list go to our premarket losers page.

Back

PHIO PHARMACEUTICALS CORP

NASDAQ:PHIO (5/8/2024, 9:15:22 PM)

Premarket: 0.8793 +0.08 (+9.91%)

0.8

-0.04 (-4.35%)

PHIO News

News Image9 days ago - Phio Pharmaceuticals Corp.Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)

-Phio’s lead clinical product candidate, PH-762, is the focus of dermatological poster presentation...

News Image16 days ago - ChartmillTuesday's pre-market session: top gainers and losers

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

News Image16 days ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!

News Image17 days ago - ChartmillMonday's after hours session: top gainers and losers

The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

News Image17 days ago - ChartmillWhich stocks are experiencing notable movement on Monday?

Top movers in Monday's session

News Image17 days ago - Phio Pharmaceuticals Corp.Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells

-Injection in murine tumors shows the compound is well tolerated -Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment...

News Image23 days ago - Phio Pharmaceuticals Corp.Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)

Phio’s lead clinical product candidate, PH-762, is the subject of three new dermatological posters...

News Imagea month ago - Phio Pharmaceuticals Corp.Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)

MARLBOROUGH, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose...

News Imagea month ago - Phio Pharmaceuticals Corp.National Spotlight Features Phio’s Innovative RNAi Technology Platform

—Program will be airing on PBS with Dennis Quaid in April —It will also be seen on Fox Business Network MARLBOROUGH, Mass., April 03, 2024 (GLOBE...

News Imagea month ago - BusinessInsiderPHIO Stock Earnings: Phio Pharma Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Phio Pharma (NASDAQ:PHIO) just reported results for the fourth quarter of 2023....

News Imagea month ago - InvestorPlacePHIO Stock Earnings: Phio Pharma Beats EPS for Q4 2023

PHIO stock results show that Phio Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - Phio Pharmaceuticals Corp.Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
PHIO Links
Follow us for more